Key points from article :
From 1 October, hospitals will analyse and interpret patient DNA.
Precision medicine offers therapies tailored to individual patients.
Tumour DNA will be screened for key mutations.
Can identify best drug to use, or appropriate clinical trials.
Knowing how many mutations a lung tumour has indicates how it will respond.